logo
The best summer AC temperature? Experts have an unpopular answer.

The best summer AC temperature? Experts have an unpopular answer.

Yahoo4 hours ago

Summer 2025 is here and temperatures are reaching dangerous levels, making air conditioning important for comfort and safety.
But what temperature should you set your thermostat at? The answer is a balancing act between energy savings, comfort and safety.
'It is essential to stay cool during hot weather — use air conditioning or go to a cool place where you feel comfortable,' Dr. Michelle Morse, New York City's acting health commissioner, said in a statement. 'Heat is dangerous, but taking certain precautions can prevent illness and protect your health.'
People also have bills to pay as AC demand skyrockets. Here are ways to stay cool while balancing budgets.
Summer 2025 brings killer heat. Here are some surprising ways to stay safe.
The best temperature to set your air conditioning is 78 degrees Fahrenheit when you wake up, according to the U.S. Environmental Protection Agency's Energy Star program. Energy companies in Florida, Maryland and Missouri also recommend thermostats at 78 degrees during summer months.
Not many people follow this recommendation, as a 2021 Consumer Reports survey showed. And a 2024 poll from the Detroit Free Press, part of the USA TODAY Network, found 72 degrees was a favorite among readers.
But setting your thermostat at a higher temperature can maximize efficiency.
As temperatures ideally drop at night, people should set thermostats 4 degrees warmer when they go to sleep.
If you're away from home, you can avoid unnecessary energy usage by setting temperatures 7 degrees warmer, the energy department said. Even 7 to 10 degrees, for around 8 hours daily, can save up to 10% annually on cooling and heating.
Since windows bring in heat, window curtains can help keep indoors cooler.
Look for air leaks — such as windows, baseboards and doors — and seal them to keep cool air in and hot air outside.
Reduce use of appliances that generate heat, such as stoves or ovens.
Use fans to circulate cool air, but don't use them as your only cooling device.
There are other methods to stay cool, which USA TODAY compiled here. You should also check on others who may be more vulnerable to heat-related illness, including young children, older people and people with chronic health issues.
If it gets too hot, look for a nearby cooling center. Even public areas, such as malls, museums or pools, can give critical respite.
Contributing: Jeanine Santucci and Greta Cross, USA TODAY.
Eduardo Cuevas is based in New York City. Reach him by email at emcuevas1@usatoday.com or on Signal at emcuevas.01.
This article originally appeared on USA TODAY: Experts say this is best AC temperature amid heat wave

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Together Women's Health Welcomes The Perinatal Group as First Maternal Fetal Medicine Partner
Together Women's Health Welcomes The Perinatal Group as First Maternal Fetal Medicine Partner

Yahoo

time30 minutes ago

  • Yahoo

Together Women's Health Welcomes The Perinatal Group as First Maternal Fetal Medicine Partner

DETROIT, June 24, 2025--(BUSINESS WIRE)--Together Women's Health (TWH) proudly announces its new partnership with The Perinatal Group, a premier and trusted leader in maternal fetal medicine (MFM) care in Tennessee and Kentucky. This partnership marks the first MFM group to join the TWH network and adds 4 board-certified MFM physicians. Together Women's Health is a women's health-focused management service organization, committed to partnering with leading physicians to build a premier network of women's health services in the U.S. TWH's affiliate network consists of 20 practices with over 180 providers delivering women's health services at over 45 locations throughout Michigan, Illinois, Alabama, Colorado, Mississippi, Missouri, Georgia, Tennessee and Kentucky. Founded by Dr. Sal Lombardi and Dr. Kathleen Mayor-Lynn, The Perinatal Group has built a legacy spanning more than 40 years and is known for delivering compassionate, expert care for high-risk pregnancies with the latest technology and is accredited by the prestigious American Institute of Ultrasound in Medicine in Obstetric Ultrasound, High-Risk Obstetric Ultrasound, Fetal Echocardiography, and Gynecologic Ultrasound. The practice is widely recognized for its advanced ultrasound services, diagnostic capabilities, and team of experienced MFM specialists. "For over 40 years, The Perinatal Group has provided leading high-risk obstetric care to women across Middle Tennessee and Southern Kentucky. As the first maternal fetal medicine practice to join Together Women's Health, we're proud to bring our specialized expertise in complex pregnancy management and advanced MFM ultrasound to this growing community of exceptional OB providers," said Dr. Sal Lombardi, partner and maternal fetal medicine specialist of The Perinatal Group. "We believe the best outcomes happen when compassionate, collaborative care guides every step of the pregnancy journey." By joining TWH, The Perinatal Group will collaborate closely with a broader network of OB-GYN practices, expanding access to expert-level consultation, diagnostics, and care coordination for women experiencing high-risk or complicated pregnancies. "We are honored to welcome The Perinatal Group to Together Women's Health as our first Maternal Fetal Medicine partner," said Anthony Ahee, CEO of Together Women's Health. "Their decades-long commitment to delivering high-quality, compassionate care for high-risk pregnancies aligns perfectly with our mission. This partnership enhances our ability to support women with complex needs and strengthens our comprehensive care model across the region and throughout the TWH network." This affiliation is another step in Together Women's Health's strategy to be the most trusted name in women's health. To learn more about a partnership with Together Women's Health, visit or contact us at partner@ About Together Women's Health Headquartered in Detroit, MI, Together Women's Health ("TWH") is a women's health management services organization committed to partnering with leading physicians to build a premier network of obstetricians and gynecologists. TWH, recently named on the Inc. 5000 list of fastest growing companies in America, supports its affiliated practices and physician partners throughout multiple states with strategic guidance, administrative resources (including revenue cycle management, marketing, human resources, finance, accounting, and IT), operational expertise and capital, thereby allowing physicians to focus on clinical excellence and serving their communities. TWH is building a network of top clinicians in a physician-led culture. For more information about Together Women's Health, please visit About Shore Capital Partners Shore Capital, a Chicago-based private equity firm with offices in Nashville, is an investor in lower middle market companies in the Healthcare, Food and Beverage, Business Services, Industrial, and Real Estate industries. Shore's strategy is to support management partners to grow faster with less risk through access to capital, world-class board and operational resources, and unmatched networking, development, and shared learnings across the portfolio. From 2020-2023, Shore received recognition from Inc Magazine as a 4x Top Founder Friendly Investor and by Pitchbook Research for being the global leader in Private Equity total deal volume. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant potential to grow through industry consolidation and organic growth to generate value for shareholders. Shore has $9.1 billion of assets under management and in additional investment platforms to which it provides business and operational consulting services. For more information on these awards and investment platforms, please visit: View source version on Contacts Media Contact Suzanne Cooper, Vice President of Marketing Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Shift Toward Targeted Drug Delivery Systems and Non-invasive Treatment Options is Poised to Transform the Landscape
Shift Toward Targeted Drug Delivery Systems and Non-invasive Treatment Options is Poised to Transform the Landscape

Yahoo

time30 minutes ago

  • Yahoo

Shift Toward Targeted Drug Delivery Systems and Non-invasive Treatment Options is Poised to Transform the Landscape

The global acute on chronic liver failure (ACLF) market is witnessing a transformation with a focus on innovative solutions like gene therapies and regenerative medicine. These advancements offer new ways to tackle the condition's root causes, while targeted drug delivery systems and non-invasive treatments promise more effective, patient-friendly options. However, the lack of FDA-approved therapies limits market growth. North America is expected to lead due to its robust healthcare infrastructure. Key market drivers include rising investments in R&D and the increasing prevalence of liver diseases. Companies like Grifols Therapeutics, GENFIT, and Martin Pharmaceuticals are pioneering progress in this burgeoning field. Dublin, June 24, 2025 (GLOBE NEWSWIRE) -- The "Acute On Chronic Liver Failure Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has been added to growing focus on innovative solutions like gene therapies and regenerative medicine technologies offers significant potential for the global acute on chronic liver failure market, introducing new ways to address the root causes of the condition. Additionally, the shift toward targeted drug delivery systems and non-invasive treatment options is poised to transform the treatment landscape, providing more effective and patient-friendly alternatives that could further propel market the lack of FDA-approved therapies for acute on chronic liver failure remains a key challenge, limiting the availability of effective treatment options and hindering market expansion. On a positive note, the continuous improvement of healthcare infrastructure in emerging economies presents a considerable opportunity for market growth, as increased access to treatments becomes more America is expected to dominate the global acute on chronic liver failure market due to established healthcare systems, high treatment adoption rates, and significant investments in healthcare infrastructure. Key Market Players and Competition SynopsisThe companies profiled in this report are based on extensive research and insights from primary experts, evaluating company coverage, product portfolios, and market penetration. The leading players in the global acute on chronic liver failure market include pharmaceutical companies making significant advancements in therapies for liver failure. These companies play a crucial role in improving patient outcomes and addressing the growing demand for effective treatments for liver diseases. How Can This Report Add Value to an Organization?Product/Innovation Strategy: This report provides comprehensive insights into the current treatments and market trends for acute on chronic liver failure, helping organizations identify opportunities for new product development. By focusing on unmet needs, particularly in the areas of antiviral therapies, liver support agents, and organ transplantation, companies can innovate to meet the growing demand for effective ACLF Strategy: To maintain a competitive edge in the acute on chronic liver failure market, companies should focus on improving the safety and efficacy of existing treatments, advancing liver transplantation technologies, and exploring strategic partnerships with research institutions and healthcare providers. Expanding market access in emerging markets and investing in public awareness campaigns will also be critical to gaining market - Drivers and Limitations The demand drivers for the global acute on chronic liver failure market are: Ongoing investment in research and development of new drug classes, including antivirals and immunosuppressants for acute on chronic liver failure, is propelling market growth The rising prevalence of chronic liver diseases, especially cirrhosis and chronic hepatitis, is contributing to a higher occurrence of acute on chronic liver failure, thereby fuelling the demand for effective treatments Limitations: The lack of FDA-approved therapies for acute on chronic liver failure restricts access to effective treatments, impeding market growth Some of the prominent pharmaceutical companies established in the global acute on chronic liver failure market include: Grifols Therapeutics LLC GENFIT Corp Martin Pharmaceuticals Key Topics Covered: 1. Global Acute On Chronic Liver Failure Market: Industry Outlook1.1 Market Overview and Ecosystem1.2 Epidemiological Analysis of Acute On Chronic Liver Failure1.2.1 By Region1.3 Market Trends1.4 Clinical Trial Analysis1.4.1 By Phase1.5 Regulatory Landscape Analysis1.5.1 Legal Requirement and Framework in U.S.1.5.2 Legal Requirement and Framework in E.U.1.5.3 Legal Requirement and Framework in Asia-Pacific1.6 Market Dynamics1.6.1 Impact Analysis1.6.2 Market Drivers1.6.3 Market Restraints1.6.4 Market Opportunities2. Global Acute On Chronic Liver Failure Market, by Region, $Million, 2023-20352.1 North America2.1.1 Key Findings2.1.2 Market Dynamics2.1.3 Market Sizing and Forecast2.1.3.1 North America Acute On Chronic Liver Failure Market (by Country)2.1.3.1.1 U.S.2.2 Europe2.2.1 Key Findings2.2.2 Market Dynamics2.2.3 Market Sizing and Forecast2.2.3.1 Europe Acute On Chronic Liver Failure Market (by Country)2.2.3.1.1 Germany2.2.3.1.2 France2.2.3.1.3 Italy2.2.3.1.4 U.K.2.3 Asia-Pacific2.3.1 Key Findings2.3.2 Market Dynamics2.3.3 Market Sizing and Forecast2.3.3.1 Asia-Pacific Acute On Chronic Liver Failure Market (by Country)2.3.3.1.1 Japan2.4 Rest-of-the-World2.4.1 Key Findings2.4.2 Market Dynamics2.4.3 Market Sizing and Forecast3. Global Acute On Chronic Liver Failure Market: Competitive Benchmarking and Company Profiles3.1 Competitive Landscape3.1.1 Key Strategies and Developments by Company3.1.1.1 Funding Activities3.1.1.2 Mergers and Acquisitions3.1.1.3 Regulatory Approvals3.1.1.4 Partnerships, Collaborations and Business Expansions3.1.2 Key Developments Analysis3.2 Company Profiles3.2.1 Grifols Therapeutics LLC3.2.1.1 Company Overview3.2.1.2 Product Portfolio3.2.1.3 Target Customers/End Users3.2.1.4 Key Personnels3.2.1.5 Analyst View3.2.2 GENFIT Corp3.2.2.1 Company Overview3.2.2.2 Product Portfolio3.2.2.3 Target Customers / End Users3.2.2.4 Key Personnels3.2.2.5 Analyst View3.2.3 Martin Pharmaceuticals3.2.3.1 Company Overview3.2.3.2 Product Portfolio3.2.3.3 Target Customers / End Users3.2.3.4 Key Personnels3.2.3.5 Analyst View4. Research Methodology For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Tolion Announces Collaboration with Garmin, Global Leader in Advanced Wellness and Fitness Smartwatches, in Preparation for 2025 U.S. Launch of Tolion Brain Coach Mobile Application
Tolion Announces Collaboration with Garmin, Global Leader in Advanced Wellness and Fitness Smartwatches, in Preparation for 2025 U.S. Launch of Tolion Brain Coach Mobile Application

Yahoo

time30 minutes ago

  • Yahoo

Tolion Announces Collaboration with Garmin, Global Leader in Advanced Wellness and Fitness Smartwatches, in Preparation for 2025 U.S. Launch of Tolion Brain Coach Mobile Application

Collaboration Provides Unique Synergy to Enhance Tolion Brain Coach Mobile Application Recommendations Based on Each User's Unique Data Tolion Artificial Intelligence Solutions Help Users Improve Brain Health and Performance by Identifying and Addressing Modifiable Risk Factors Personalized Recommendations with Insights Based on Individual Lifestyle Profiles Have Potential for Vast Impact on Health, Quality of Life, and Longevity Garmin Supports Tolion Applications by Providing Access to Broad Range of Health Metrics from Extensive Smartwatch and Fitness Tracker Portfolio Upcoming U.S. Launch of Tolion Brain Coach Mobile Application in Late 2025 BOSTON, June 24, 2025--(BUSINESS WIRE)--Tolion Health, Inc., a digital health company developing artificial intelligence (AI) solutions for personalized, predictive and preventive lifestyle recommendations to improve brain health and longevity, today announced its collaboration with Garmin through its Garmin Health division. The integration of the Garmin Connect Developer Program (Health API) into Tolion products allows users of the Tolion Brain Coach mobile application to seamlessly utilize their health data from the extensive Garmin smartwatch and fitness tracker portfolio to further improve their personalized lifestyle recommendations. Early access users may enroll in the pilot version of Tolion Brain Coach application. "At Tolion, we identify modifiable personal risk factors that impair brain health and performance and leverage our unique medical knowledge-base and AI software to address health risks and improve quality of life while enhancing longevity. The Garmin Health collaboration will advance our services by integrating the rich data generated by Garmin wearables, including a wide array of health metrics," said Martin Tolar, MD, PhD, Founder and Director of Tolion Health, Inc. "We are well funded to launch the Tolion Brain Coach mobile application in the U.S. by the end of this year and look forward to the impact of our first product. The Tolion Brain Coach provides access to immense amounts of medical knowledge and expertise that is not currently readily available to patients and practitioners and has the potential to improve the lives of millions of healthy individuals as well as people predisposed to Alzheimer's disease and dementia." The integration of the Garmin Health API into Tolion products enable Garmin users to opt in to share real-time sensor data with the Tolion Brain Coach mobile application to help individuals optimize their lifestyle and improve brain health and performance for long-term wellness and longevity. The Tolion Brain Coach mobile application will now feature biometric sensor data such as activity details, Body Battery™, sleep, stress, heart rate and many others from Garmin smartwatches and fitness trackers. "Tolion Health, through its commitment to developing innovative digital health solutions for conditions like Alzheimer's and dementia, showcases the potential of leveraging the high-quality biometric data of Garmin smartwatches and fitness trackers," said Jörn Watzke, Senior Director, Garmin Health. "Prevention continues to be a key area of focus for forward-thinking companies like Tolion, and we are honored to be a collaborator on this exciting initiative." The Garmin Health team and Tolion share the mission to empower personalized health decisions through the aggregation and analysis of wearable data. This collaboration encompasses: Healthcare applications including remote patient monitoring, digital therapeutics, and rehabilitation Corporate wellness and employee engagement programs Risk assessment, disease prevention, and customer loyalty programs Research and clinical trials "Tolion is a leader in preventive healthcare technology and our collaboration with Garmin marks a major milestone enabling seamless integration of health, activity and biometric data from Garmin wearables into the Tolion Brain Coach. This integration allows us to deliver highly personalized, AI-driven recommendations to predict and prevent health risks, guiding users toward better brain health and longevity," said Ing. Jaroslav Lískovec, CEO of Tolion Health CZ s.r.o., the Czech subsidiary of Tolion Health, Inc. "While treatment options for neurodegenerative disorders continue to advance, preventive medicine remains largely underdeveloped. By leveraging artificial intelligence solutions, our personalized lifestyle recommendation plans generated by the Tolion Brain Coach mobile application, with insights based on individual habits, medical status, and genetic background, can improve quality of life and help prevent or delay the progression of Alzheimer's disease and other neurodegenerative disorders." About Tolion Brain CoachTolion products provide personalized, AI-driven guidance for brain health, performance and longevity. By emphasizing prevention, we can improve quality of life and significantly reduce the incidence and impact of devastating conditions. The Tolion Brain Coach mobile application represents a breakthrough in brain health solutions by providing personalized guidance with features including: 1. Risk assessment for brain health, improved performance & longevity Empowers users with personalized health assessment & risk insights Tailored to each user's unique health data 2. Analysis of lifestyle changes & interventions Evaluates impact of lifestyle changes Defines long-term effects on reshaping one's risk score & performance 3. Machine learning driven health predictions Provides insight into user's health trajectories Applies digital twin approach for cutting-edge predictions The proprietary Tolion AI Engine integrates advanced AI technologies, including knowledge management systems, automated reasoning, machine learning and large language models. These technologies enable targeted, personalized interventions that improve cognitive health and overall performance. The Tolion AI Engine powers the Tolion Brain Coach mobile application by combining the latest medical knowledge related to brain health and neurodegenerative disorders with detailed user-specific data. The initial goal of Tolion products is to improve brain health, enhance longevity, and reduce risks of neurodegenerative conditions such as Alzheimer's disease. The Tolion Brain Coach strives to advance the fight against Alzheimer's disease and other neurodegenerative disorders by shifting the focus from reactive treatment to proactive prevention. Age is the most important risk factor for these disorders, and as the global population ages, the risk of cognitive decline and disability increases. Scientific research shows that preventive interventions can lower dementia risk by more than 45%, thereby delaying or even preventing onset of advanced symptoms that can be life-altering for patients and their families. Early access users may enroll in the pilot version of Tolion Brain Coach mobile application. About TolionTolion Health, Inc., is a digital health company leveraging the power of AI, data, and collaborative technologies to deliver holistic personalized, preventive, and predictive care. Supported by a dedicated team of medical experts, Tolion integrates advanced technology with actionable insights, empowering patients to take control of their health, prevent disability, and improve performance. Tolion comprehensive brain health solutions powered by proprietary Tolion MedPortal and Tolion AI Engine systems identify and address modifiable personal risk factors that impair brain health and performance to improve quality of life and enhance longevity. The Tolion MedPortal is a next-generation medical knowledge management platform that applies AI to process vast amounts of data from scientific papers and medical studies to scale, verify, and continuously refine knowledge foundation for our products. The Tolion AI Engine uses this continuously evolving knowledge to provide personalized health insights based on genetics, family history, performance and medical status to individual users. Our innovative Tolion Brain Coach mobile application provides access to immense amounts of medical knowledge and expertise that is not currently readily available to patients and practitioners, and enables early prevention, accurate diagnosis, and continuous care, ensuring that everyone has the necessary tools to achieve a better quality of life and improved outcomes of health interventions. About Garmin HealthGarmin Health, a leading provider of digital health solutions that leverage sensor data and insights of the Garmin product ecosystem, delivers custom results for corporate wellness, population health and patient monitoring programs. By using the Garmin Health API and SDK, third parties can seamlessly integrate real-time and historical smartwatch data into their apps in accordance with their specific privacy policies. As part of a global company that designs, manufactures and ships products worldwide, Garmin Health empowers enterprises to work with a single, trusted provider. For more information, email our media team, connect with us on LinkedIn or visit us online at For more information visit Follow us on LinkedIn. Early access users may enroll in the pilot version of Tolion Brain Coach application. View source version on Contacts Media Contact Tereza Kulhánková+420 731 142 Investor Contact Petr Zmatlo+420 603 861 Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store